MONTREAL, Dec. 6 /CNW/ - CryoCath Technologies Inc. (TSX: CYT), the
global leader in cryotherapy products to treat cardiac arrhythmias, today
announced that Jan Keltjens, President and CEO of CryoCath, will present on
the 'Breaking Through Old Barriers: New Opportunities' panel at the 2007 RBC
Healthcare Conference at The Westin New York at Times Square in New York City
on Thursday, December 13. Mr. Keltjens will present a market outlook and
discuss some recent events and upcoming milestones, including the STOP AF IDE
Trial for Arctic Front(R), the Company's minimally invasive cryo-balloon
catheter designed specifically to treat paroxysmal atrial fibrillation.
